learn more about
clinical trials
clinical trials
Scientific Research
Fortetropin inhibits disuse muscle atrophy in dogs after tibial plateau leveling osteotomy
This study supports the use of a myostatin inhibitor, Fortetropin®, to prevent disuse muscle atrophy in canine patients undergoing a tibial plateau leveling osteotomy.
Evaluating the Safety and Tolerability of Fortetropin® in Cats
The recommended dosing range of Fortetropin for cats was unknown prior to this study. The purpose of this study was to evaluate the safety and tolerability of Fortetropin in 12 purpose-bred cats.
Evaluation of Fortetropin in geriatric and senior dogs with reduced mobility
The purpose of this randomized, double-blinded, placebo-controlled study was to evaluate the effects of Fortetropin, a nonthermal-pasteurized, freeze-dried, fertilized egg yolk product, on mobility in senior dogs.
In a Randomized, Placebo-Controlled Cross-Over Study, Administration of 6 and 12 G Fortetropin® Does Not Reduce Serum Myostatin in Healthy Adult Dogs Over 72-Hours
A study by Sharp et al. evaluating Fortetropin supplementation showed promising results in both myostatin inhibition and muscle hypertrophy.
